Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.1666
+0.0006 (0.36%)
May 14, 2026, 5:28 PM CET
EPA:ALVIO Market Cap
EPA:ALVIO has a market cap or net worth of €82.91 million as of May 14, 2026. Its market cap has increased by 753.35% in one year.
Market Cap
82.91M
Enterprise Value
90.17M
Revenue
2.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.17
Market Cap Chart
Since December 8, 2005, EPA:ALVIO's market cap has increased from 72.77M to 82.91M, an increase of 13.93%. That is a compound annual growth rate of 0.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 82.91M | 22.90% |
| Dec 31, 2025 | 67.46M | 484.18% |
| Dec 31, 2024 | 11.55M | -54.58% |
| Dec 29, 2023 | 25.42M | 62.58% |
| Dec 30, 2022 | 15.64M | -59.41% |
| Dec 31, 2021 | 38.52M | -25.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 245.21M |
| Sensorion | 213.87M |
| Transgene | 212.53M |
| MaaT Pharma | 135.67M |
| ABIONYX Pharma | 128.41M |
| Innate Pharma | 118.41M |
| OSE Immunotherapeutics | 99.28M |
| Adocia | 96.60M |